Press Resease

Compounding Pharmacies Market - Global Industry Analysis

Compounding Pharmacies Market By Product Type (Oral, Topical, Mouthwashes, Suppositories, Injectables, and Ophthalmic), By Therapeutic Type (Hormone Replacement and Pain Management), and by End-users (Adult, Pediatric, Geriatric, and Veterinary): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 11-Aug-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2525 Status : Published

Global compounding pharmacies market expected to generate revenue of around USD 13,910.0 million by end of 2024, growing at a CAGR of around 6.2% between 2018 and 2024. Every patient is different and has unique needs for which customized medications are a critical part of quality medical service and patient care.

Description

The report covers the forecast and analysis for the compounding pharmacies market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the compounding pharmacies market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the compounding pharmacies market on a global level.

In order to give the users of this report a comprehensive view of the compounding pharmacies market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type segment, therapeutic segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Compounding Pharmacies Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the compounding pharmacies market by segmenting the market based on product type, therapeutic type, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product type, the market is segmented into oral, topical, mouthwashes, suppositories, injectables, and ophthalmic. Based on the therapeutic type, the market is segmented into hormone replacement and pain management category. The end-users are classified into an adult, pediatric, geriatric, and veterinary. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, the U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes demand for compounding pharmacies market based on individual product type, therapeutic type, and end-users in all the regions and countries.

The report also includes detailed profiles of end players such as AmerisourceBergen, Rx3 Pharmacy, Agbi’s Sterile Compounding Pharmacy LLC, B. Braun Medical Inc., Cantrell Drug Company, Inc., Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd., Village Sterile Compounding Pharmacy, Imprimis Pharmaceuticals, Inc., Institutional Pharmacies Of Louisiana LLC, Lorraine's Pharmacy, McGuff Sterile Compounding Pharmacy Services, Inc., Panaceutics Inc., Pencol Compounding Pharmacy, Fagron, ITC Compounding Pharmacy, SCA Pharmaceuticals, Wedgewood Pharmacy, Fresenius Kabi AG, and Dougherty's Holdings, Inc.  

This report segments the global compounding pharmacies market as follows:

Global Compounding Pharmacies Market: Product Type Segment Analysis

  • Oral 
  • Topical
  • Mouthwashes
  • Suppositories
  • Injectables
  • Ophthalmic

Global Compounding Pharmacies Market: Therapeutic Type Segment Analysis

  • Hormone Replacement 
  • Pain Management 

Global Compounding Pharmacies Market: End-user Segment Analysis

  • Adult
  • Pediatric
  • Geriatric
  • Veterinary

Global Compounding Pharmacies Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Compounding Pharmacies market, 2017 - 2024 (USD Million)
    • 2.2. Global Compounding Pharmacies market: snapshot
  •  
  • Chapter 3. Compounding Pharmacies Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Compounding Pharmacies Market drivers: impact analysis
      • 3.2.2. Rising Geriatric Population
      • 3.2.3. Growing acceptance of personalized medicines in developed nations
    • 3.3. Market Restraints
      • 3.3.1. Global Compounding Pharmacies Market restraints: impact analysis
      • 3.3.2. Cost competitiveness
      • 3.3.3. Lack of Skilled Lab Technicians and Pharmacists In Developing Economies
    • 3.4. Opportunities
      • 3.4.1. Rising regulatory supervision of manufacturing facilities
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product type segment
      • 3.6.2. Market attractiveness analysis, by therapeutic type segment
      • 3.6.3. Market attractiveness analysis, by end-users segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Compounding Pharmacies Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Compounding Pharmacies Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Compounding Pharmacies Market- Product Segment Analysis
    • 5.1. Global Compounding Pharmacies Market: product overview
      • 5.1.1. Global Compounding Pharmacies Market revenue share, by product, 2017 and 2024
    • 5.2. Oral
      • 5.2.1. Global Compounding Pharmacies Market for Oral Compounding Pharmacies Market, 2017 - 2024 (USD Million)
        • 5.2.1.1. Global Oral Compounding Pharmacies Market for capsules, 2017 - 2024 (USD Million)
        • 5.2.1.2. Global Oral Compounding Pharmacies Market for tablets, 2017 - 2024 (USD Million)
        • 5.2.1.3. Global Oral Compounding Pharmacies Market for suspension, 2017 - 2024 (USD Million)
        • 5.2.1.4. Global Oral Compounding Pharmacies Market for lozenges, 2017 - 2024 (USD Million)
        • 5.2.1.5. Global Oral Compounding Pharmacies Market for lollipops, 2017 - 2024 (USD Million)
    • 5.3. Topical
      • 5.3.1. Global Compounding Pharmacies Market for Topical Compounding Pharmacies Market, 2017 - 2024 (USD Million)
        • 5.3.1.1. Global Topical Compounding Pharmacies Market for creams, 2017 - 2024 (USD Million)
        • 5.3.1.2. Global Topical Compounding Pharmacies Market for gels, 2017 - 2024 (USD Million)
        • 5.3.1.3. Global Topical Compounding Pharmacies Market for ointments, 2017 - 2024 (USD Million)
        • 5.3.1.4. Global Topical Compounding Pharmacies Market for lotions, 2017 - 2024 (USD Million)
    • 5.4. Mouthwashes
      • 5.4.1. Global Compounding Pharmacies Market for Mouthwashes Compounding Pharmacies Market, 2017 - 2024 (USD Million)
    • 5.5. Suppositories
      • 5.5.1. Global Compounding Pharmacies Market for Suppositories Compounding Pharmacies Market, 2017 - 2024 (USD Million)
    • 5.6. Injectables
      • 5.6.1. Global Compounding Pharmacies Market for Injectables Compounding Pharmacies Market, 2017 - 2024 (USD Million)
        • 5.6.1.1. Global Injectable Compounding Pharmacies Market for injections, 2017 - 2024 (USD Million)
        • 5.6.1.2. Global Injectable Compounding Pharmacies Market for infusions, 2017 - 2024 (USD Million)
        • 5.6.1.3. Global Injectable Compounding Pharmacies Market for concentrates, 2017 - 2024 (USD Million)
        • 5.6.1.4. Global Injectable Compounding Pharmacies Market for powders for reconstitution, 2017 - 2024 (USD Million)
        • 5.6.1.5. Global Injectable Compounding Pharmacies Market for gels, 2017 - 2024 (USD Million)
    • 5.7. Ophthalmic
      • 5.7.1. Global Compounding Pharmacies Market for Ophthalmic Compounding Pharmacies Market, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global Compounding Pharmacies Market- Therapeutic Type Segment Analysis
    • 6.1. Global Compounding Pharmacies Market: Therapeutic type overview
      • 6.1.1. Global Compounding Pharmacies Market revenue share, by Therapeutic type, 2017 and 2024
    • 6.2. Hormone Replacement
      • 6.2.1. Global Compounding Pharmacies Market for Hormone Replacement market, 2017 - 2024 (USD Million)
    • 6.3. Pain Management
      • 6.3.1. Global Compounding Pharmacies Market for Pain Management market, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global Compounding Pharmacies Market- End-user Segment Analysis
    • 7.1. Global Compounding Pharmacies Market: End-user overview
      • 7.1.1. Global Compounding Pharmacies Market revenue share, by End-user, 2017 and 2024
    • 7.2. Adult
      • 7.2.1. Global Compounding Pharmacies Market for Adult, 2017 - 2024 (USD Million)
    • 7.3. Pediatric
      • 7.3.1. Global Compounding Pharmacies Market for Pediatric, 2017 - 2024 (USD Million)
    • 7.4. Geriatric
      • 7.4.1. Global Compounding Pharmacies Market for Geriatric, 2017 - 2024 (USD Million)
    • 7.5. Veterinary
      • 7.5.1. Global Compounding Pharmacies Market for Veterinary, 2017 - 2024 (USD Million)
  •  
  • Chapter 8. Global Compounding Pharmacies Market- Regional Segment Analysis
    • 8.1. Global Compounding Pharmacies Market: regional overview
      • 8.1.1. Global Compounding Pharmacies Market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
      • 8.2.2. North America Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
      • 8.2.3. North America Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.2.4.2. U.S. Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.2.4.3. U.S. Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.2.5.2. Rest of North America Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.2.5.3. Rest of North America Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
      • 8.3.2. Europe Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
      • 8.3.3. Europe Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.3.4.2. U.K. Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.3.4.3. U.K. Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.3.5.2. Germany Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.3.5.3. Germany Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.6. France`
        • 8.3.6.1. France Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.3.6.2. France Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.3.6.3. France Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.3.7.2. Italy Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.3.7.3. Italy Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.3.8.2. Spain Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.3.8.3. Spain Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Compounding Pharmacies Market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.9.2. Rest of Europe Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.3.9.3. Rest of Europe Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
      • 8.4.2. Asia Pacific Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
      • 8.4.3. Asia Pacific Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.4.4.2. China Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.4.4.3. China Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.4.5.2. Japan Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.4.5.3. Japan Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.4.6.2. India Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.4.6.3. India Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.4.7.2. Southeast Asia Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.4.7.3. Southeast Asia Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
      • 8.5.2. Latin America Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
      • 8.5.3. Latin America Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.5.4.2. Brazil Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.5.4.3. Brazil Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.5.5.2. Rest of Latin America Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.5.5.3. Rest of Latin America Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
      • 8.6.2. Middle East and Africa Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
      • 8.6.3. Middle East and Africa Compounding Pharmacies Market revenue, by end user, 2017 - 2024 (USD Million)
      • 8.6.4. GCC Countries
        • 8.6.4.1. GCC Countries Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.6.4.2. GCC Countries Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.6.4.3. GCC Countries Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.6.5. South Africa
        • 8.6.5.1. South Africa Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.6.5.2. South Africa Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.6.5.3. South Africa Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.6.6. Rest of Middle East and Africa
        • 8.6.6.1. Rest of Middle East and Africa Compounding Pharmacies Market revenue, by product, 2017 - 2024 (USD Million)
        • 8.6.6.2. Rest of Middle East and Africa Compounding Pharmacies Market revenue, by therapeutic type, 2017 - 2024 (USD Million)
        • 8.6.6.3. Rest of Middle East and Africa Compounding Pharmacies Market revenue, by end-users, 2017 - 2024 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. AmerisourceBergen
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Rx3 Pharmacy
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Agbi's Sterile Compounding Pharmacy LLC
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. B. Braun Medical Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Cantrell Drug Company, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Village Sterile Compounding Pharmacy
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Imprimis Pharmaceuticals, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Institutional Pharmacies Of Louisiana LLC
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Lorraine's Pharmacy
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. McGuff Sterile Compounding Pharmacy Services, Inc.
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Therapy portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Panaceutics Inc.
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Therapy portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments
    • 9.13. Pencol Compounding Pharmacy
      • 9.13.1. Overview
      • 9.13.2. Financials
      • 9.13.3. Therapy portfolio
      • 9.13.4. Business strategy
      • 9.13.5. Recent developments
    • 9.14. Fagron
      • 9.14.1. Overview
      • 9.14.2. Financials
      • 9.14.3. Therapy portfolio
      • 9.14.4. Business strategy
      • 9.14.5. Recent developments
    • 9.15. ITC Compounding Pharmacy
      • 9.15.1. Overview
      • 9.15.2. Financials
      • 9.15.3. Therapy portfolio
      • 9.15.4. Business strategy
      • 9.15.5. Recent developments
    • 9.16. SCA Pharmaceuticals
      • 9.16.1. Overview
      • 9.16.2. Financials
      • 9.16.3. Therapy portfolio
      • 9.16.4. Business strategy
      • 9.16.5. Recent developments
    • 9.17. Wedgewood Pharmacy
      • 9.17.1. Overview
      • 9.17.2. Financials
      • 9.17.3. Therapy portfolio
      • 9.17.4. Business strategy
      • 9.17.5. Recent developments
    • 9.18. Fresenius Kabi AG
      • 9.18.1. Overview
      • 9.18.2. Financials
      • 9.18.3. Therapy portfolio
      • 9.18.4. Business strategy
      • 9.18.5. Recent developments
    • 9.19. Dougherty's Holdings, Inc.
      • 9.19.1. Overview
      • 9.19.2. Financials
      • 9.19.3. Therapy portfolio
      • 9.19.4. Business strategy
      • 9.19.5. Recent developments

Methodology

Free Analysis

The pharmacies which produce the drugs tailored to the individual patient needs, based on the doctor’s or physician’s prescription are called compound pharmacies. Compounded drugs are the amalgamation of two or more drug ingredients in different proportions, i.e., combining or altering the active pharmaceutical ingredients of drugs to meet the unmet medical need of an individual patient.  The major driver of compounding pharmacies market is worldwide increasing geriatric population. The population aged 60 or above is growing rapidly thus the demand for anti-aging products which use custom compounded drugs are increasing. The compounding medicines are made as per the required dose and concentration as per patient need. Moreover, the ease of administering compounded drugs is particularly distinguished in critical illnesses such as cancer, where a patient is incapable to swallow a pain-reducing drug. The drug is either administered as a transdermal application, lollipop, or sterile preparation. The high advantages of compounded drugs over commercial medicines on an individual patient will propel the market during the forecast period.

These drugs formation process is carried out under the supervision of licensed medical practitioners or pharmacist. However, compounded medications are not approved by many regulatory authorities globally owing to its safety and effectiveness concerns. Compounded medications are not FDA approved. Furthermore, these drugs are mostly not reimbursed by pharmaceutical benefit agencies, which may hamper the growth of the global compounding pharmacies market in the near future.

Global Compounding Pharmacies Market

The global compounding pharmacies market is segmented on the basis of product type which is further divided into oral, topical, mouthwashes, suppositories, injectables, and ophthalmic. The oral product type is further segmented into capsules, tablets, suspension, lozenges, and lollipops. The topical products are further classified into creams, gels, ointments, and lotions. The injectables segment is sub-segmented into injections, infusions, concentrates, powders for reconstitution, and gels. Among which oral product segment dominates the market, owing to the convenience of oral medication, safe, and non-invasive route of administration, which will increase the patient preference for oral medications thus fueling the growth of oral segment during the forecast period.

North America held a dominant share for the global market for compounding pharmacies in 2017 and region is projected to continue with its regional supremacy in the forthcoming years as well. The growth of this regional market is attributed with the favorable government policies, high acceptance of compounded drugs, and increasing number of compounding pharmacies in the region. Asia Pacific is projected to grow at a significant CAGR due to rising healthcare infrastructure. Moreover, increase in the research & development activities with regards to improvement in the several healthcare outcomes and to obtain more accurate and precise results will propel the growth of the compounding pharmacies market in Asia Pacific region. Increasing incidences of chronic disorders and augmentation in the geriatric population will also increase the burden on the healthcare economy and will drive the market during the forecast period.

Some of the key players in the compounding pharmacies market are AmerisourceBergen, Rx3 Pharmacy, Agbi’s Sterile Compounding Pharmacy LLC, B. Braun Medical Inc., Cantrell Drug Company, Inc., Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd., Village Sterile Compounding Pharmacy, Imprimis Pharmaceuticals, Inc., Institutional Pharmacies Of Louisiana LLC, Lorraine's Pharmacy, McGuff Sterile Compounding Pharmacy Services, Inc., Panaceutics Inc., Pencol Compounding Pharmacy, Fagron, ITC Compounding Pharmacy, SCA Pharmaceuticals, Wedgewood Pharmacy, Fresenius Kabi AG, and Dougherty's Holdings, Inc. Currently, the market’s growth rate is increasing, which has encouraged the players to focus on consolidation through product licensing and long-term partnerships in order to gain maximum share in the market.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social